Today, South-East Asia accounts for no less than 2/3 of the world's swine production and nearly 70% of the world's aquaculture production. To address new animal health challenges such as mass vaccination, food safety and the emergence of new diseases in this area, we will strengthen our R&D activities with a new R&D center in the region to be opened in two years time in Taiwan. 

On November 26, we therefore celebrated the groundbreaking of this brand new R&D center in the Ping Toung technopole, a technology park located in the southwest of the region and close to our production units in Kaohsiung. "With a surface area of 850 m², our unit's main objective will be to define, optimize and validate the processes involved in the manufacture of viral and bacterial vaccines and immunity adjuvants for several animal species, mainly swine and aquaculture production", said Jules Minke, Corporate biology R&D director. Construction work will start in the first quarter of 2020, with qualification and commissioning scheduled for the last quarter of 2021. 

At Virbac, our R&D teams are developing all over the world to better respond to the various challenges of animal health. With this in mind, we also inaugurated a new center in Uruguay at the end of 2019 and a unit specializing in aquaculture will join the campus of Nong Lam University (Vietnam) in September 2020.